Skip to main content
Equibles
OFIX logo

OFIX · Orthofix Medical Inc. · Metrics

Track OFIX — free

Use OFIX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OFIX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$8.69 -0.22 (-2.47%) At close · Sep 10
Russell 2000 member Rebalance outlook locked
Market Cap
$362.93M
Shares
40.73M

OFIX metrics

72 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$8.69
Market cap
$362.93M

Price action

20 metrics
Price change (1W)
-5.0%
Price change (30D)
-13.7%
Price change (3M)
-8.4%
Price change (6M)
-27.4%
Price change (YTD)
-41.2%
Price change (1Y)
-39.0%
Trailing year
Price change (5Y)
-78.5%
52-week high
$16.23
52-week low
$8.91
Change from 52-week high
-45.1%
Change from 52-week low
+0.0%
Annualized volatility
46.9%
Annualized volatility (3M)
62.6%
Beta
0.7
RSI (14D)
29.7
Price vs SMA 50
-16.2%
Price vs SMA 200
-27.2%
Avg volume (3M)
368,906
Relative volume
1.5
Average dollar volume
$3.82M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
40.73M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.4×
reciprocal yield 229.6%
P / book
0.8
reciprocal yield 118.3%
FCF yield
-7.7%
TTM · current market cap
Buyback yield
17.5%
P / FCF
—
P / operating cash flow
22.3
reciprocal yield 4.5%
Earnings yield
-17.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.8×
reciprocal yield 125.3%
EV / revenue historical average (5Y)
0.8×
reciprocal yield 125.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
17.5%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
71.3%
Operating margin
-4.7%
Trailing 12 months
Net margin
-7.4%
Gross profit (TTM)
$594.12M
Operating profit (TTM)
−$39.12M
Net income (TTM)
−$61.72M
Trailing 12 months
Diluted EPS (TTM)
$-1.53
FCF margin
-3.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$10.78

Growth

11 metrics
Revenue growth YoY
+3.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$833.19M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.6%
Year over year · more shares
Revenue CAGR (3Y)
+21.3%
Revenue CAGR (5Y)
+15.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-14.4%
Return on assets
-7.1%
Debt / equity
—
Current ratio
2.8
EBITDA (TTM)
$13.66M
Free cash flow (TTM)
−$27.82M
Quick ratio
1.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$103.81M
Total assets
$873.02M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$16.27M
Capital expenditures (TTM)
$44.09M
R&D (TTM)
$61.41M
SG&A (TTM)
$557.80M
Stock compensation (TTM)
$28.66M
R&D / revenue
7.4%
Stock compensation / revenue
3.4%

Ownership (13F)

3 metrics
13F filers
143
13F filer change QoQ
-4
Institutional ownership
94.0%

Short interest

3 metrics
Short interest
5.8%
Latest settlement · 9.2 days to cover
Days to cover
9.2d
Short-squeeze score
63 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$451,644
Insider-sentiment score
25 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 884624 CUSIP 68752M108 13F (30d) 85 filings 85 filers Visit website Investor relations